Table 2 Relationship between the expression of miR-198-5p and clinicopathological features in LUSC patients
From: Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR
Clinicopathological feature | n | miR-198-5p expression (2−ΔCq) | |||
|---|---|---|---|---|---|
Mean ± SD | t | P | |||
Tissue | LUSC | 23 | 4.3826 ± 1.7660 | 0.146 | 0.885 |
|  | Non-tumor | 23 | 4.4522 ± 1.8263 |  |  |
Gender | Male | 18 | 4.4670 ± 1.8711 | 0.425 | 0.675 |
|  | Female | 5 | 4.0800 ± 1.4584 |  |  |
Age | < 60 | 15 | 4.0930 ± 1.4270 | − 1.080 | 0.293 |
|  | ≥ 60 | 8 | 4.9250 ± 2.2833 |  |  |
Smoking state | No | 12 | 4.3000 ± 1.2884 | − 0.229 | 0.821 |
|  | Yes | 11 | 4.4730 ± 2.2401 |  |  |
Size | ≤ 3 cm | 7 | 4.2570 ± 2.1196 | − 0.220 | 0.828 |
|  | > 3 cm | 16 | 4.4380 ± 1.6633 |  |  |
EGFR amplification | No | 17 | 4.7470 ± 1.8084 | 1.741 | 0.096 |
|  | Yes | 6 | 3.3500 ± 1.2357 |  |  |
Vascular invasion | No | 20 | 4.6100 ± 1.6914 | 1.656 | 0.113 |
|  | Yes | 3 | 2.8670 ± 1.7786 |  |  |
TNM stage | I-II | 10 | 5.4400 ± 1.5277 | 2.917 | 0.008 |
|  | III-IV | 13 | 3.5690 ± 1.5228 |  |  |
LNM | No | 11 | 4.8730 ± 2.0553 | 1.294 | 0.210 |
|  | Yes | 12 | 3.9330 ± 1.3918 |  |  |
EGFR protein | Low | 18 | 4.3280 ± 1.9013 | − 0.277 | 0.785 |
|  | High | 5 | 4.5800 ± 1.3142 |  |  |
MET | Low | 13 | 4.9230 ± 1.6559 | 1.750 | 0.095 |
|  | High | 10 | 3.6800 ± 1.7313 |  |  |
Grading | II | 16 | 4.4130 ± 1.8326 | 0.12 | 0.906 |
|  | III | 7 | 4.3140 ± 1.7411 |  |  |